Targeting Mitochondria 2021 Speakers

Targeting Mitochondria 2021-Volkmar-Weissig Introduction Note
Volkmar Weissig
, President of the World Mitochondria Society, Midwestern University, USA

Mitochondrial DNA in cancer: The overlooked oncogenomeMitochondrial DNA in cancer: The overlooked oncogenome
Payam A. Gammage, CRUK Beatson Institute, United Kingdom
targeting mitochondria 2021 Dr. Claire McCoyMitochondrial arginase-2 is essentialfor IL-10 metabolic reprogrammingof inflammatory macrophages
Claire McCoy, Royal College of Surgeons in Ireland, Ireland 
Glucose Metabolism Control of T Cell ImmunityGlucose Metabolism Control of T Cell Immunity
Ming Li, Immunology Program, Memorial Sloan Kettering Cancer Center, USA

Targeting Mitochondria 2021 Stephen-P. Chelko-v1Exercise-induced, mitochondrial-mediated cell death in Arrhythmogenic Cardiomyopathy
Stephen Chelko, Florida State University, USA

Patient-specific brain organoids for modeling mitochondrial diseasesPatient-specific brain organoids for modeling mitochondrial diseases
Alessandro Prigione, Heinrich Heine University (HHU), Germany

A Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease PatientsA Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients
Paulo J. Oliveira, University of Coimbra, Portugal